Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Theranostics Market Size Changed, over the years?

The size of the theranostics market has experienced considerable expansion in the past few years. It is projected to escalate from a market value of $111.1 billion in 2024 to $123.33 billion in 2025, with a compound annual growth rate (CAGR) of 11.0%. The remarkable growth in the past period has been driven by factors such as improvements in molecular imaging, a transition towards value-based healthcare, and integration within oncology.

How Much Will the Theranostics Market Be Worth in 2029?

The market size of theranostics is anticipated to experience a rapid expansion in the upcoming years. The market is predicted to reach a valuation of “$185.73 billion by 2029, growing at a Compound Annual Growth Rate (CAGR) of 10.8%. Factors contributing to this growth during the forecast period include the surge in precision medicine initiatives, growing applications beyond oncology, an aging population coupled with chronic diseases, developments in biomarker detection, as well as governmental backing and funding. Key trends identified for the forecast period encompass regulatory support, the advent of companion diagnostics, increased emphasis on cancer theranostics, patient involvement and awareness, and technology convergence.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10823&type=smp

Which is the Largest Company in the Theranostics Market?

Major companies operating in the theranostics market include Abbott Laboratories, Agilent Technologies Inc., AmeriPath Inc, Beckman Coulter Inc., Thermo Fisher Scientific Inc, Astellas Pharma, Helmholtz Centre for Infection Research, Radiopharm Theranostics Ltd, Alpha- Theranostics, UNIVERZITET U NOVOM SADU, Cardio-Theranostics LLC, Curium, SoFi Technologies Inc., Theradiag, Cell Theranostics, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc, Qiagen NV, Foundation Medicine Inc, Leica Biosystems Nussloch GmBH, Pfizer Inc., Siemens Healthineers, Advanced Accelerator Applications, AstraZeneca plc, Bayer AG, Bio-Rad Laboratories, The Bristol-Myers Squibb Company, Danaher Corporation, MilliporeSigma, Illumina Inc., Merck KGaA, Roche Diagnostics Corporation, PerkinElmer Inc.

What Are the Main Market Drivers in the Theranostics Industry?

The increasing incidence of cancer globally is predicted to trigger the expansion of the theranostics market. Cancer is defined by the unchecked proliferation of cells that affects various organs and leads to noteworthy morbidity and mortality worldwide. Theranostics, a fusion of therapeutic and diagnostic procedures, offers remarkable potential in managing cancer and chronic diseases. It facilitates personalized and targeted remedies by merging diagnostic and treatment capabilities, thus providing avenues for healthcare industry innovation. Consequently, the rise in cancer cases will fuel the growth of the theranostics sector. For example, the National Cancer Institute (NCI), a US-based government institution of National Institutes of Health (NIH) committed to cancer research, prevention, and treatment, noted in January 2022 that about 5.4% of the American population or roughly 18.1 million people are survivors of cancer. Moreover, 623,405 individuals were living with metastatic forms of various cancers including breast, prostate, lung, colorectal, bladder, or melanoma in 2022, a number that is anticipated to reach 693,452 by 2025. Thus, the mounting prevalence of cancer is stimulating the theranostics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10823&type=smp

How Is the Theranostics Market Segments Structured?

The theranostics market covered in this report is segmented –

1) By Disease Type: Neurological Disorders, Cardiovascular Diseases, Immunological Disorders, Oncology Diseases, Other Diseases

2) By Technology: Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Sequencing, Other Technologies

3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Neurological Disorders: Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Epilepsy, Other Neurological Disorders

2) By Cardiovascular Diseases: Coronary Artery Disease, Heart Failure, Atrial Fibrillation, Hypertension, Other Cardiovascular Diseases

3) By Immunological Disorders: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Inflammatory Bowel Disease, Psoriasis, Other Immunological Disorders

4) By Oncology Diseases: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Other Oncology Diseases

5) By Other Diseases: Infectious Diseases, Metabolic Disorders, Genetic Disorders, Other Diseases

What Strategic Trends Are Transforming the Theranostics Market?

Leading corporations in the theranostics market are looking to innovate and advance their offerings, including theranostics clinical trials. This field merges diagnostic testing with targeted treatment to personalize healthcare and enhance patient results. The effectiveness of various therapies decided by patient-specific biomarkers adds depth to the personalization. In 2024, the American cancer treatment center, BAMF Health, began the COMBAT Trial, or “A Phase I/II Theranostic Study of 64Cu-SAR-BBN and 67Cu-SAR-BBN for Identification and Treatment of GRPR-expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617” (NCT05633160). The trial, launched within seven weeks through the organization’s BAMF RapAct program, revolves around innovative radiopharmaceuticals that target the Gastrin-Releasing Peptide receptor (GRPR). The study strives to expand treatment alternatives for patients with scarce therapeutic options.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/theranostics-global-market-report

Which Global Regions Offer the Highest Growth in the Theranostics Market?

North America was the largest region in the global theranostics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the theranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10823

This Report Delivers Insight On:

1. How big is the theranostics market, and how is it changing globally?

2. Who are the major companies in the theranostics market, and how are they performing?

3. What are the key opportunities and risks in the theranostics market right now?

4. Which products or customer segments are growing the most in the theranostics market?

5. What factors are helping or slowing down the growth of the theranostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model